Ulgel Liquid 170 ml

babies: not applicable. lactating mothers: it is safe to use this medicine during breastfeeding.
human studies suggest that the drug does not cause significant risk to the baby. pregnancy: please consult your doctor before using this medicine.
information regarding the use of this medicine during pregnancy is not available. alcohol: it is unsafe to consume alcohol while using this medicine.
driving: this medicine does not affect your ability to drive. it is safe to go while using this medicine.
kidney: please consult your doctor before using this medicine. there is limited information available on the use of this medicine in patients with kidney disease.
liver: please consult your doctor before using this medicine. there is limited information available on the use of this medicine in patients with liver disease..

Diarrhea Constipation Chalky taste.

ULGEL is a combination medicine used to treat acidity, bloating, indigestion, and stomach ulcers. magaldrate is an inorganic salt that neutralizes excess acid in the stomach.
simethicone is an antifoaming agent that disintegrates gas bubbles and allows easy passage of gas..

If you miss a dose of ULGEL, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• you should take ULGEL after meals or as directed by a doctor • avoid drinking hot tea, coffee, spicy foods, and chocolate. instead, drink cold milk and cold coffee as this will help neutralize stomach acid • avoid smoking and alcohol • avoid eating late at night or before bed • do not take these tablets for at least 2 hours before or after taking other medicines as this drug may interact with other drugs • talk to your doctor if you experience signs of appendicitis such as pelvic pain, cramping, gas, nausea, and vomiting.

• (magaldrate + simethicone) + glimepiride: concurrent use of this medicine alters the blood glucose levels • (magaldrate + simethicone) + raltegravir: concurrent use leads to a decrease in the therapeutic effect of raltegravir • (magaldrate + simethicone) + enalapril: concurrent use leads to an increase in the risk of potassium levels • (magaldrate + simethicone) + chloroquine: concurrent use leads to an increase in the risk of irregular heart rate • (magaldrate + simethicone) + aspirin: concurrent use leads to a decrease in the therapeutic effect of aspirin.